Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 2/20 | 0.45 |
| ▸ | TRPM8 | Q7Z2W7 | 2/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA4 | P22748 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12449332 | 1.00 | TRPA1 (0.45) | TRPA1TRPM8CA1CA2CA4 | |
| SCHEMBL2151294 | 1.00 | TRPA1 (0.45) | TRPA1TRPM8CA1CA2CA4 | |
| SCHEMBL2162465 | 1.00 | TRPA1 (0.45) | TRPA1TRPM8CA1CA2CA4 | |
| SCHEMBL31571716 | 1.00 | TRPA1 (0.45) | TRPA1TRPM8CA1CA2CA4 | |
| SCHEMBL15369721 | 0.83 | CA1 (0.46) | TRPA1TRPM8CA1CA2CA4 | |
| SCHEMBL6757779 | 0.83 | CA1 (0.46) | TRPA1TRPM8CA1CA2CA4 | |
| SCHEMBL6757782 | 0.83 | CA1 (0.46) | TRPA1TRPM8CA1CA2CA4 | |
| SCHEMBL6757777 | 0.83 | CA1 (0.46) | TRPA1TRPM8CA1CA2CA4 | |
| SCHEMBL15369688 | 0.83 | CA1 (0.46) | TRPA1TRPM8CA1CA2CA4 | |
| SCHEMBL6757780 | 0.83 | CA1 (0.46) | TRPA1TRPM8CA1CA2CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3821225-B1 | FIXATIVE SOLUTION AND METHOD OF PREPARATION OF BIOLOGICAL SAMPLE | APACOR LTD (GB) | 2023-07-05 | — | — | EP | claimed |
| US-12601660-B2 | Fixative solution and method of preparation of biological sample | APACOR LIMITED (GB) | 2026-04-14 | — | — | US | disclosed |
| US-20260014098-A1 | FENCHOL AS A STIMULATOR OF FREE FATTY ACID RECEPTOR AND OTHER USES THEREOF | UNIV SOUTH FLORIDA (US) | 2026-01-15 | — | — | US | disclosed |
| US-12447135-B2 | Fenchol as a stimulator of free fatty acid receptor and other uses thereof | UNIVERSITY OF SOUTH FLORIDA (US) | 2025-10-21 | — | — | US | disclosed |
| US-20250290009-A1 | NEW LOW SULFUR TERPENE MIX RECOVERY FROM WOOD PROCESSING | FIRMENICH SA (CH) | 2025-09-18 | — | — | US | disclosed |
| US-20250137015-A1 | YEAST PLATFORM FOR RENEWABLE INDUSTRIAL TERPENE PRODUCTION | Wang, Zhen (US) | 2025-05-01 | — | — | US | disclosed |
| EP-4522714-A1 | NEW LOW SULFUR TERPENE MIX RECOVERY FROM WOOD PROCESSING | Firmenich SA (CH) | 2025-03-19 | — | — | EP | disclosed |
| CN-119173616-A | Recovery of novel low sulfur terpene mixtures from wood processing | 弗门尼舍有限公司 | 2024-12-20 | — | — | CN | disclosed |
| US-20240410055-A1 | METHOD AND FORMULATION FOR PREPARING OPTICAL METAL OXIDE LAYERS | MERCK PATENT GMBH (DE) | 2024-12-12 | — | — | US | disclosed |
| US-20240108040-A1 | HIGH INTENSITY SWEETENERS | FIRMENICH INCORPORATED (US) | 2024-04-04 | — | — | US | disclosed |
| CN-110891615-B | System and method for selecting and releasing fragrance | 阿甘香气及精细化学有限公司 | 2022-08-05 | — | — | CN | disclosed |
| WO-2022129608-A2 | ENZYMES AND METHODS FOR FERMENTATIVE PRODUCTION OF MONOTERPENE ESTERS | ISOBIONICS B.V. (NL) | 2022-06-23 | — | — | WO | disclosed |
| EP-4015626-A1 | ENZYMES AND METHODS FOR FERMENTATIVE PRODUCTION OF MONOTERPENE ESTERS | Isobionics B.V. (NL) | 2022-06-22 | — | — | EP | disclosed |
| EP-3368542-B1 | HIGH INTENSITY SWEETENERS | FIRMENICH INCORPORATED (US) | 2022-06-22 | — | — | EP | disclosed |
| US-11357246-B2 | High intensity sweeteners | FIRMENICH INCORPORATED (US) | 2022-06-14 | — | — | US | disclosed |
| EP-2292224-B1 | Derivatives of lactiosole for preventing or treating diabetes | SYMRISE AG (DE) | 2018-03-07 | — | — | EP | disclosed |
| CN-106999972-A | System and method for discharging fragrance | 阿甘芳香和精细化工有限公司 | 2017-08-01 | — | — | CN | disclosed |
| US-8592621-B2 | Precursor compounds of sweet taste receptor antagonists for the prevention or treatment of disease | SYMRISE AG (DE) | 2013-11-26 | — | — | US | disclosed |
| EP-2292224-A1 | Precursor compounds of sweet receptor antagonists for preventing or treating diabetes | Symrise AG (DE) | 2011-03-09 | — | — | EP | disclosed |
| US-20110045069-A1 | PRECURSOR COMPOUNDS OF SWEET TASTE RECEPTOR ANTAGONISTS FOR THE PREVENTION OR TREATMENT OF DISEASE | SYMRISE GMBH CO. KG (DE) | 2011-02-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12601660-B2 | Fixative solution and method of preparation of biological sample | CA3, CA2, CA1 | TRPA1 421/4885TRPM8 288/4885CA1 3/4885 |
| US-20240108040-A1 | HIGH INTENSITY SWEETENERS | TAS2R40, TAS2R60, TAS1R1 | TRPA1 179/4885TRPM8 180/4885CA1 1475/4885 |
| US-11357246-B2 | High intensity sweeteners | TAS2R40, TAS2R60, TAS1R1 | TRPA1 179/4885TRPM8 180/4885CA1 1475/4885 |
| US-20260014098-A1 | FENCHOL AS A STIMULATOR OF FREE FATTY ACID RECEPTOR AND OTHER USES THEREOF | FFAR2, FFAR1, FFAR3 | TRPA1 605/4885TRPM8 651/4885CA1 3069/4885 |
| US-12447135-B2 | Fenchol as a stimulator of free fatty acid receptor and other uses thereof | FFAR2, FFAR1, FFAR3 | TRPA1 1911/4885TRPM8 1388/4885CA1 2613/4885 |
| US-20110045069-A1 | PRECURSOR COMPOUNDS OF SWEET TASTE RECEPTOR ANTAGONISTS FOR THE PREVENTION OR TREATMENT OF DISEASE | TAS1R2, TAS2R5, TAS2R1 | TRPA1 241/4885TRPM8 132/4885CA1 3071/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.